INTUNIV

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Japan, Lithuania, Netherlands, Poland, Spain, UK.

Active ingredients

The drug INTUNIV contains one active pharmaceutical ingredient (API):

1	Guanfacine UNII PML56A160O - GUANFACINE HYDROCHLORIDE
	Guanfacine is a selective alpha2A-adrenergic receptor agonist in that it has 15-20 times higher affinity for this receptor subtype than for the alpha2B or alpha2C subtypes. Guanfacine is a non-stimulant. The mode of action of guanfacine in ADHD is not fully established.
	Read more about Guanfacine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INTUNIV Prolonged-release tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02AC02	Guanfacine	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AC Imidazoline receptor agonists
Discover more medicines within C02AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11440D, 11441E, 11451Q, 11452R
CA	Health Products and Food Branch	02409100, 02409119, 02409127, 02409135
EE	Ravimiamet	1697159, 1697160, 1697171, 1697182, 1697193, 1697216, 1697227, 1697238, 1697249
ES	Centro de información online de medicamentos de la AEMPS	1151040002, 1151040004, 1151040006, 1151040008
FI	Lääkealan turvallisuus- ja kehittämiskeskus	074927, 118421, 185859, 422340
FR	Base de données publique des médicaments	60359196, 61979798, 64928499, 69756377
GB	Medicines & Healthcare Products Regulatory Agency	310741, 310744, 310747, 310750
IE	Health Products Regulatory Authority	21569, 21947, 23158, 24514, 55531
JP	医薬品医療機器総合機構	1179057G1021, 1179057G2028
LT	Valstybinė vaistų kontrolės tarnyba	1078597, 1078598, 1078599, 1078600, 1078601, 1078602, 1078603, 1078604, 1078605
NL	Z-Index G-Standaard, PRK	135321, 135348, 135356, 135364
PL	Rejestru Produktów Leczniczych	100090715, 100126175, 100157974, 100236001
US	FDA, National Drug Code	54092-513, 54092-515, 54092-517, 54092-519